Evolve BioSystems raises $9 mln

Evolve BioSystems Inc. said Monday it raised $9 million Series A round led by Horizons Ventures. Seed stage investors in the company, including Tate & Lyle Ventures and a number of angel Investors also participated. Davis, California-based Evolve is a microbiotics company.

17 August 2015•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail